首页 > 市场调查报告书 > 製药

癌症呼吸器

市场调查报告书

商品编码

1387369

鼻咽癌市场报告：2030 年趋势、预测与竞争分析

Nasopharyngeal Cancer Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年11月01日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

鼻咽癌的趋势和预测

预计2024年至2030年全球鼻咽癌市场将以3.4%的年复合成长率成长。该市场的主要驱动因素是鼻咽癌盛行率的增加以及政府对癌症研究和倡议的资助的增加。全球鼻咽癌市场的未来充满希望，医院和诊所以及门诊手术中心市场充满机会。

鼻咽癌市场洞察

Lucintel 预测，化疗预计在预测期内增长最快，因为它被认为是杀死癌细胞的高效治疗方法。

由于对其他环境中通常无法获得的专业设备和专业知识的需求不断增加，医院和诊所将继续成为该市场中最大的部分。

由于癌症发生率高以及治疗和诊断意识的提高，北美在预测期内仍然是最大的地区。

本报告回答了 11 个关键问题：

Q.1. 细分市场中最有前途和高成长的机会是什么？
Q.2.哪个细分市场将以更快的速度成长？为什么？
Q.3.您认为哪些地区未来会出现更快的成长？为什么？
Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
Q.5. 这个市场的商业风险和竞争威胁是什么？
Q.6.这个市场有哪些新趋势？为什么？
Q.7.市场客户需求有何改变？
Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

成长机会分析
- 全球鼻咽癌治疗市场成长机会
- 全球鼻咽癌市场成长机会（依最终用途）
- 全球鼻咽癌市场按地区成长机会
全球鼻咽癌市场新趋势
战略分析
- 新产品开发
- 全球鼻咽癌市场的产能扩张
- 全球鼻咽癌收购和合资企业
- 认证和许可

第7章主要企业概况

Biocon
Bristol-Myers Squibb Company
Cyclacel Pharmaceuticals
F. Hoffman-La Roche
Merck & Co
Novartis
Pfizer
Sanofi
Theravectys
Eli Lilly and Company

简介目录

Nasopharyngeal Cancer Trends and Forecast

The future of the global nasopharyngeal cancer market looks promising with opportunities in the hospitals and clinic and ambulatory surgery center markets. The global nasopharyngeal cancer market is expected to grow with a CAGR of 3.4% from 2024 to 2030. The major drivers for this market are growing incidence of nasopharyngeal cancer and increasing government funding for cancer research and initiatives.

A more than 150-page report is developed to help in your business decisions.

Nasopharyngeal Cancer by Segment

The study includes a forecast for the global nasopharyngeal cancer by therapy, end use, and region.

Nasopharyngeal Cancer Market by Therapy [Shipment Analysis by Value from 2018 to 2030]:

Chemotherapy
Immunotherapy
Radiation Therapy
Others

Nasopharyngeal Cancer Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

Hospitals and Clinics
Ambulatory Surgery Centers
Others

Nasopharyngeal Cancer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Nasopharyngeal Cancer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nasopharyngeal cancer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nasopharyngeal cancer companies profiled in this report include-

Biocon
Bristol-Myers Squibb Company
Cyclacel Pharmaceuticals
F. Hoffman-La Roche
Merck & Co
Novartis
Pfizer
Sanofi
Theravectys
Eli Lilly and Company

Nasopharyngeal Cancer Market Insights

Lucintel forecasts that chemotherapy is expected to witness highest growth over the forecast period as it is considered as very effective treatment for killing cancer cells.

Within this market, hospitals and clinics will remain the largest segment due to growing need to access to specialized equipment and expertise that is not typically available in other settings.

North America will remain the largest region over the forecast period due to high prevalence of cancer and growing awareness towards treatment and diagnosis in the region.

Features of the Global Nasopharyngeal Cancer Market

Market Size Estimates: Nasopharyngeal cancer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nasopharyngeal cancer market size by therapy, end use, and region in terms of value ($B).

Regional Analysis: Nasopharyngeal cancer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapies, end uses, and regions for the nasopharyngeal cancer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nasopharyngeal cancer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for nasopharyngeal cancer market?

Answer: The global nasopharyngeal cancer market is expected to grow with a CAGR of 3.4% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the nasopharyngeal cancer market?

Answer: The major drivers for this market are growing incidence of nasopharyngeal cancer and increasing government funding for cancer research and initiatives.

Q3. What are the major segments for nasopharyngeal cancer market?

Answer: The future of the nasopharyngeal cancer market looks promising with opportunities in the hospitals and clinic and ambulatory surgery center markets.

Q4. Who are the key nasopharyngeal cancer market companies?

Answer: Some of the key nasopharyngeal cancer companies are as follows:

Biocon
Bristol-Myers Squibb Company
Cyclacel Pharmaceuticals
F. Hoffman-La Roche
Merck & Co
Novartis
Pfizer
Sanofi
Theravectys
Eli Lilly and Company

Q5. Which nasopharyngeal cancer market segment will be the largest in future?

Answer: Lucintel forecasts that chemotherapy is expected to witness highest growth over the forecast period as it is considered as very effective treatment for killing cancer cells.

Q6. In nasopharyngeal cancer market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of cancer and growing awareness towards treatment and diagnosis in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the nasopharyngeal cancer market by therapy (chemotherapy, immunotherapy, radiation therapy, and others), end use (hospitals and clinics, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Nasopharyngeal Cancer Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Nasopharyngeal Cancer Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Nasopharyngeal Cancer Market by Therapy
- 3.3.1: Chemotherapy
- 3.3.2: Immunotherapy
- 3.3.3: Radiation Therapy
- 3.3.4: Others
3.4: Global Nasopharyngeal Cancer Market by End Use
- 3.4.1: Hospitals and Clinics
- 3.4.2: Ambulatory Surgery Centers
- 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Nasopharyngeal Cancer Market by Region
4.2: North American Nasopharyngeal Cancer Market
- 4.2.2: North American Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others
4.3: European Nasopharyngeal Cancer Market
- 4.3.1: European Nasopharyngeal Cancer Market by Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, and Others
- 4.3.2: European Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others
4.4: APAC Nasopharyngeal Cancer Market
- 4.4.1: APAC Nasopharyngeal Cancer Market by Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, and Others
- 4.4.2: APAC Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others
4.5: ROW Nasopharyngeal Cancer Market
- 4.5.1: ROW Nasopharyngeal Cancer Market by Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, and Others
- 4.5.2: ROW Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Nasopharyngeal Cancer Market by Therapy
- 6.1.2: Growth Opportunities for the Global Nasopharyngeal Cancer Market by End Use
- 6.1.3: Growth Opportunities for the Global Nasopharyngeal Cancer Market by Region
6.2: Emerging Trends in the Global Nasopharyngeal Cancer Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Nasopharyngeal Cancer Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nasopharyngeal Cancer Market
- 6.3.4: Certification and Licensing